AgenT

AgenT is a life sciences company founded in 2018 with its headquarters in France. The company's slogan, "Detect Alzheimer's earlier, when it could be prevented," reflects its mission to combat Alzheimer's disease by targeting the silent phase. AgenT utilizes a combination of multi-omics assays and advanced machine learning techniques to identify new blood biomarkers deregulated from the earliest stages of the disease. This data is used to develop accurate blood diagnoses and the next generation of precision therapies to treat Alzheimer’s. AgenT recently secured a €2.30M Seed Round investment on 01 July 2021, with Bernard Majoie as the lead investor. This financial support will likely play a crucial role in advancing AgenT's research and development efforts in the fight against Alzheimer's disease. With a focus on early detection and prevention, AgenT may have the potential to make a significant impact in the biotechnology, healthcare, and life sciences industries.